Related Experiment Video
Updated: Sep 12, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Familial hyperkalemic hypertension - a case report with patients in three generations]
Mikael Oscarson1, Lisa Juntti-Berggren2
1överläkare, med dr, ME endokrinolog, Centrum för medfödda metabola sjukdomar, Karolinska -universitets-sjukhuset Solna.
Insights
Genetic testing identified a KLHL3 gene variant causing familial hyperkalemic hypertension in four patients. Hydrochlorothiazide treatment normalized potassium and improved blood pressure, highlighting the value of genetic insights for personalized medicine.
Area of Science:
- Genetics
- Nephrology
- Internal Medicine
Background:
- Advancements in sequencing technologies facilitate the identification of monogenic diseases.
- Precision medicine offers tailored therapies for various conditions.
- Hyperkalemia of unclear origin can present diagnostic challenges.
Purpose of the Study:
- To present a case series of four patients across three generations diagnosed with hyperkalemia.
- To investigate the genetic basis of familial hyperkalemic hypertension in this cohort.
- To evaluate the efficacy of hydrochlorothiazide treatment for this condition.
Main Methods:
- Detailed family history collection.
- Genetic testing to identify pathogenic variants.
- Clinical assessment and monitoring of potassium levels and blood pressure.
Main Results:
- A pathogenic variant in the KLHL3 gene was identified, confirming familial hyperkalemic hypertension.
- Hydrochlorothiazide treatment normalized serum potassium levels in all affected patients.
- Significant improvement in blood pressure was observed, particularly in a patient with long-standing resistant hypertension.
Conclusions:
- Genetic testing combined with family history is crucial for diagnosing rare genetic disorders like familial hyperkalemic hypertension.
- Targeted therapy, such as hydrochlorothiazide, can effectively manage hyperkalemia and hypertension in KLHL3-related disorders.
- This case highlights the success of precision medicine in treating genetically defined conditions.
Abstract:
Recent advancements in sequencing technologies have enabled both the identification of many monogenic diseases and the development of precision medicine, enabling tailored therapies for many patients. This case presentation describes four patients across three generations diagnosed with hyperkalemia of unclear origin. Genetic testing revealed a pathogenic variant in the KLHL3 gene, linked to familial hyperkalemic hypertension. Treatment with hydrochlorothiazide essentially normalised the potassium levels for all patients, and the oldest patient, with a resistant hypertension since a young age, had a dramatic improvement in blood pressure. This case underscores the importance of a detailed family history combined with genetic testing, which can lead to tailored and effective treatments.
More Related Videos
11:33Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Chronic Kidney Disease III: Interprofessional Care
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Chronic Kidney Disease I: Introduction
Hypertension I: Introduction